Skip to main content
Fig. 1 | Virology Journal

Fig. 1

From: Platelet-derived sCD40L: specific inflammatory marker for early-stage severe acute respiratory syndrome coronavirus 2 infection

Fig. 1

Plasma levels of sCD40L and sCD62P biomarkers in patients with severe COVID-19 throughout the disease course. Individual values and mean ± 95% confidence intervals are plotted for each sampling day (D1, D3–5, D7, and D14). A mixed model was used to evidence the significant changes in sCD62P and sCD40L levels in patients with COVID-19. The Tukey multiple-comparisons test was used to compare sCD62P and sCD40L values between COVID-19 and convalescent patients (*p < 0.05; **p < 0.005; ***p < 0.001; ****p < 0.0001)

Back to article page

Virology Journal

ISSN: 1743-422X